{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:27:49Z","timestamp":1789187269827,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Interleukin (IL)-7 signaling through CD127 is impaired in lymphocytes in cancers and chronic infections, resulting in CD8<jats:sup>+<\/jats:sup>T cell exhaustion. The mechanisms underlying CD8<jats:sup>+<\/jats:sup>T cell responses to IL-7 in melanoma remain not completely elucidated. We previously showed reduced IL-7 level in melanoma patients. Thus, the aim of this study was to investigate the effect of IL-7 regulation on CD127 expression and CD8<jats:sup>+<\/jats:sup>T cell responses in melanoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Healthy controls and primary cutaneous melanoma patients were enrolled. Membrane-bound CD127 (mCD127) expression on CD8<jats:sup>+<\/jats:sup>T cells was determined by flow cytometry. Soluble CD127 (sCD127) protein level was measured by ELISA. Total CD127 and sCD127 mRNA level was measured by real-time PCR. CD8<jats:sup>+<\/jats:sup>T cells were stimulated with recombinant human IL-7, along with signaling pathway inhibitors. CD8<jats:sup>+<\/jats:sup>T cells were co-cultured with melanoma cell line, and the cytotoxicity of CD8<jats:sup>+<\/jats:sup>T cells was assessed by measurement of lactate dehydrogenase expression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Plasma sCD127 was lower in melanoma patients compared with controls. The percentage of CD8<jats:sup>+<\/jats:sup>T cells expressing mCD127 was higher, while sCD127 mRNA level was lower in peripheral and tumor-infiltrating CD8<jats:sup>+<\/jats:sup>T cells from melanoma patients. There was no significant difference of total CD127 mRNA expression in CD8<jats:sup>+<\/jats:sup>T cells between groups. IL-7 stimulation enhanced total CD127 and sCD127 mRNA expression and sCD127 release by CD8<jats:sup>+<\/jats:sup>T cells. However, mCD127 mRNA expression on CD8<jats:sup>+<\/jats:sup>T cells was not affected. This process was mainly mediated by phosphatidylinositol 3-kinase (PI3K) pathway. CD8<jats:sup>+<\/jats:sup>T cells from melanoma patients exhibited decreased cytotoxicity. IL-7 stimulation promoted CD8<jats:sup>+<\/jats:sup>T cell cytotoxicity, while inhibition of PI3K dampened IL-7-induced elevation of CD8<jats:sup>+<\/jats:sup>T cell cytotoxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The current data suggested that insufficient IL-7 secretion might contribute to CD8<jats:sup>+<\/jats:sup>T cell exhaustion and CD127 dysregulation in patients with primary cutaneous melanoma.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12865-022-00509-0","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T12:03:38Z","timestamp":1658145818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Interleukin-7 regulates CD127 expression and promotes CD8+ T cell activity in patients with primary cutaneous melanoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Hongxia","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binjun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"issue":"3","key":"509_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"509_CR2","first-page":"1005","volume":"28","author":"M Rastrelli","year":"2014","unstructured":"Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014;28(6):1005\u201311.","journal-title":"In Vivo"},{"issue":"2","key":"509_CR3","doi-asserted-by":"publisher","first-page":"202e","DOI":"10.1097\/PRS.0000000000004571","volume":"142","author":"T Knackstedt","year":"2018","unstructured":"Knackstedt T, Knackstedt RW, Couto R, Gastman B. Malignant melanoma: diagnostic and management update. Plast Reconstr Surg. 2018;142(2):202e\u201316e.","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"509_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.det.2019.06.001","volume":"37","author":"J Dowling","year":"2019","unstructured":"Dowling J, McGregor SP, Williford P. Update on current treatment recommendations for primary cutaneous melanoma. Dermatol Clin. 2019;37(4):397\u2013407.","journal-title":"Dermatol Clin"},{"issue":"3","key":"509_CR5","doi-asserted-by":"publisher","first-page":"808","DOI":"10.4103\/jcrt.jcrt_419_21","volume":"17","author":"W Xu","year":"2021","unstructured":"Xu W, Lian B, Cui C, Guo J. The combination therapy with the cytotoxic T lymphocyte-associated antigen-4 and programmed death 1 antibody-induced asthma in a patient with advanced melanoma. J Cancer Res Ther. 2021;17(3):808\u201310.","journal-title":"J Cancer Res Ther"},{"issue":"21","key":"509_CR6","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1002\/cncr.30259","volume":"122","author":"AN Shoushtari","year":"2016","unstructured":"Shoushtari AN, Munhoz RR, Kuk D, Ott PA, Johnson DB, Tsai KK, Rapisuwon S, Eroglu Z, Sullivan RJ, Luke JJ, et al. The efficacy of anti-PD-1 agents in acral and mucosal melanoma. Cancer. 2016;122(21):3354\u201362.","journal-title":"Cancer"},{"issue":"3","key":"509_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.21873\/anticanres.11405","volume":"37","author":"J Lin","year":"2017","unstructured":"Lin J, Zhu Z, Xiao H, Wakefield MR, Ding VA, Bai Q, Fang Y. The role of IL-7 in immunity and cancer. Anticancer Res. 2017;37(3):963\u20137.","journal-title":"Anticancer Res"},{"issue":"5","key":"509_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nri2970","volume":"11","author":"CL Mackall","year":"2011","unstructured":"Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 2011;11(5):330\u201342.","journal-title":"Nat Rev Immunol"},{"key":"509_CR9","doi-asserted-by":"publisher","first-page":"4807853","DOI":"10.1155\/2017\/4807853","volume":"2017","author":"V Nguyen","year":"2017","unstructured":"Nguyen V, Mendelsohn A, Larrick JW. Interleukin-7 and Immunosenescence. J Immunol Res. 2017;2017:4807853.","journal-title":"J Immunol Res"},{"issue":"4","key":"509_CR10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/CMR.0000000000000751","volume":"31","author":"H He","year":"2021","unstructured":"He H, Qiao B, Guo S, Cui H, Li N, Liu H, Qin J, He J, Yang X, Xue W, Wang Y. Induction of T helper 17 cell response by interleukin-7 in patients with primary cutaneous melanoma. Melanoma Res. 2021;31(4):328\u201337.","journal-title":"Melanoma Res"},{"issue":"12","key":"509_CR11","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","volume":"20","author":"JT Barata","year":"2019","unstructured":"Barata JT, Durum SK, Seddon B. Flip the coin: IL-7 and IL-7R in health and disease. Nat Immunol. 2019;20(12):1584\u201393.","journal-title":"Nat Immunol"},{"issue":"3","key":"509_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","volume":"24","author":"F Carrette","year":"2012","unstructured":"Carrette F, Surh CD. IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin Immunol. 2012;24(3):209\u201317.","journal-title":"Semin Immunol"},{"issue":"5","key":"509_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1074-7613(00)80052-7","volume":"10","author":"C Pallard","year":"1999","unstructured":"Pallard C, Stegmann AP, van Kleffens T, Smart F, Venkitaraman A, Spits H. Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity. 1999;10(5):525\u201335.","journal-title":"Immunity"},{"issue":"5","key":"509_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1084\/jem.20040789","volume":"200","author":"JT Barata","year":"2004","unstructured":"Barata JT, Silva A, Brandao JG, Nadler LM, Cardoso AA, Boussiotis VA. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J Exp Med. 2004;200(5):659\u201369.","journal-title":"J Exp Med"},{"issue":"8","key":"509_CR15","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.4049\/jimmunol.180.8.5201","volume":"180","author":"NL Alves","year":"2008","unstructured":"Alves NL, van Leeuwen EM, Derks IA, van Lier RA. Differential regulation of human IL-7 receptor alpha expression by IL-7 and TCR signaling. J Immunol. 2008;180(8):5201\u201310.","journal-title":"J Immunol"},{"issue":"2","key":"509_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/icb.2012.69","volume":"91","author":"FM Ghazawi","year":"2013","unstructured":"Ghazawi FM, Faller EM, Sugden SM, Kakal JA, MacPherson PA. IL-7 downregulates IL-7Ralpha expression in human CD8 T cells by two independent mechanisms. Immunol Cell Biol. 2013;91(2):149\u201358.","journal-title":"Immunol Cell Biol"},{"issue":"12","key":"509_CR17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/intimm\/dxm102","volume":"19","author":"A Vranjkovic","year":"2007","unstructured":"Vranjkovic A, Crawley AM, Gee K, Kumar A, Angel JB. IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells. Int Immunol. 2007;19(12):1329\u201339.","journal-title":"Int Immunol"},{"issue":"2","key":"509_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2004.07.016","volume":"21","author":"JH Park","year":"2004","unstructured":"Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL, Singer A. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity. 2004;21(2):289\u2013302.","journal-title":"Immunity"},{"issue":"12","key":"509_CR19","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.4049\/jimmunol.0900190","volume":"182","author":"T Rose","year":"2009","unstructured":"Rose T, Lambotte O, Pallier C, Delfraissy JF, Colle JH. Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients. J Immunol. 2009;182(12):7389\u201397.","journal-title":"J Immunol"},{"issue":"10","key":"509_CR20","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/eji.201948453","volume":"50","author":"SC Cote","year":"2020","unstructured":"Cote SC, Burke Schinkel SC, Berthoud TK, Barros PO, Sanchez-Vidales M, Davidson AM, Crawley AM, Angel JB. IL-7 induces sCD127 release and mCD127 downregulation in human CD8(+) T cells by distinct yet overlapping mechanisms, both of which are impaired in HIV infection. Eur J Immunol. 2020;50(10):1537\u201349.","journal-title":"Eur J Immunol"},{"key":"509_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2017.12.014","volume":"102","author":"H Hou","year":"2018","unstructured":"Hou H, Kang Y, Zeng Y, Li Y, Shang J. Interleukin-7 augments CD8(+) T cells function and promotes viral clearance in chronic hepatitis C virus infection. Cytokine. 2018;102:26\u201333.","journal-title":"Cytokine"},{"key":"509_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cyto.2018.04.003","volume":"118","author":"D Teng","year":"2019","unstructured":"Teng D, Ding L, Cai B, Luo Q, Wang H. Interleukin-7 enhances anti-tumor activity of CD8(+) T cells in patients with hepatocellular carcinoma. Cytokine. 2019;118:115\u201323.","journal-title":"Cytokine"},{"issue":"2","key":"509_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nri2023","volume":"7","author":"R Mazzucchelli","year":"2007","unstructured":"Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol. 2007;7(2):144\u201354.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"509_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.smim.2012.02.006","volume":"24","author":"AM Crawley","year":"2012","unstructured":"Crawley AM, Angel JB. The influence of HIV on CD127 expression and its potential implications for IL-7 therapy. Semin Immunol. 2012;24(3):231\u201340.","journal-title":"Semin Immunol"},{"issue":"7","key":"509_CR25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/ijc.22854","volume":"121","author":"NK Vudattu","year":"2007","unstructured":"Vudattu NK, Magalhaes I, Schmidt M, Seyfert-Margolis V, Maeurer MJ. Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer. Int J Cancer. 2007;121(7):1512\u20139.","journal-title":"Int J Cancer"},{"issue":"5","key":"509_CR26","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/eji.200940093","volume":"40","author":"AM Crawley","year":"2010","unstructured":"Crawley AM, Vranjkovic A, Young C, Angel JB. Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cells. Eur J Immunol. 2010;40(5):1396\u2013407.","journal-title":"Eur J Immunol"},{"issue":"25","key":"509_CR27","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1182\/blood-2008-10-186601","volume":"113","author":"I Sereti","year":"2009","unstructured":"Sereti I, Dunham RM, Spritzler J, Aga E, Proschan MA, Medvik K, Battaglia CA, Landay AL, Pahwa S, Fischl MA, et al. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood. 2009;113(25):6304\u201314.","journal-title":"Blood"},{"issue":"43","key":"509_CR28","doi-asserted-by":"publisher","first-page":"26059","DOI":"10.1074\/jbc.M115.649509","volume":"290","author":"N Schumacher","year":"2015","unstructured":"Schumacher N, Meyer D, Mauermann A, von der Heyde J, Wolf J, Schwarz J, Knittler K, Murphy G, Michalek M, Garbers C, et al. Shedding of endogenous interleukin-6 receptor (IL-6R) is governed by a disintegrin and metalloproteinase (ADAM) proteases while a full-length IL-6R isoform localizes to circulating microvesicles. J Biol Chem. 2015;290(43):26059\u201371.","journal-title":"J Biol Chem"},{"issue":"43","key":"509_CR29","doi-asserted-by":"publisher","first-page":"35887","DOI":"10.1074\/jbc.M112.365171","volume":"287","author":"RS Chanthaphavong","year":"2012","unstructured":"Chanthaphavong RS, Loughran PA, Lee TY, Scott MJ, Billiar TR. A role for cGMP in inducible nitric-oxide synthase (iNOS)-induced tumor necrosis factor (TNF) alpha-converting enzyme (TACE\/ADAM17) activation, translocation, and TNF receptor 1 (TNFR1) shedding in hepatocytes. J Biol Chem. 2012;287(43):35887\u201398.","journal-title":"J Biol Chem"},{"issue":"2","key":"509_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/imm.13189","volume":"160","author":"HM Wang","year":"2020","unstructured":"Wang HM, Zhang XH, Ye LQ, Zhang K, Yang NN, Geng S, Chen J, Zhao SX, Yang KL, Fan FF. Insufficient CD100 shedding contributes to suppression of CD8(+) T-cell activity in non-small cell lung cancer. Immunology. 2020;160(2):209\u201319.","journal-title":"Immunology"},{"issue":"4","key":"509_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jhep.2019.05.013","volume":"71","author":"S Yang","year":"2019","unstructured":"Yang S, Wang L, Pan W, Bayer W, Thoens C, Heim K, Dittmer U, Timm J, Wang Q, Yu Q, et al. MMP2\/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance. J Hepatol. 2019;71(4):685\u201398.","journal-title":"J Hepatol"},{"issue":"4","key":"509_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/vim.2020.0311","volume":"34","author":"DN Zhang","year":"2021","unstructured":"Zhang DN, Liu Y, Li X, Gao Y, Xi FY, Li Y, Zhu GZ. Imbalance between soluble and membrane-bound CD100 regulates monocytes activity in hepatitis B virus-associated acute-on-chronic liver failure. Viral Immunol. 2021;34(4):273\u201383.","journal-title":"Viral Immunol"},{"issue":"52","key":"509_CR33","doi-asserted-by":"publisher","first-page":"44976","DOI":"10.1074\/jbc.M111.316414","volume":"286","author":"H Luo","year":"2011","unstructured":"Luo H, Wu Z, Qi S, Jin W, Han B, Wu J. Ephrinb1 and Ephrinb2 are associated with interleukin-7 receptor alpha and retard its internalization from the cell surface. J Biol Chem. 2011;286(52):44976\u201387.","journal-title":"J Biol Chem"},{"issue":"3","key":"509_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/mc.22933","volume":"58","author":"M Jian","year":"2019","unstructured":"Jian M, Yunjia Z, Zhiying D, Yanduo J, Guocheng J. Interleukin 7 receptor activates PI3K\/Akt\/mTOR signaling pathway via downregulation of Beclin-1 in lung cancer. Mol Carcinog. 2019;58(3):358\u201365.","journal-title":"Mol Carcinog"},{"issue":"9","key":"509_CR35","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/leu.2016.83","volume":"30","author":"K Cante-Barrett","year":"2016","unstructured":"Cante-Barrett K, Spijkers-Hagelstein JA, Buijs-Gladdines JG, Uitdehaag JC, Smits WK, van der Zwet J, Buijsman RC, Zaman GJ, Pieters R, Meijerink JP. MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia. Leukemia. 2016;30(9):1832\u201343.","journal-title":"Leukemia"},{"issue":"4","key":"509_CR36","doi-asserted-by":"publisher","first-page":"844","DOI":"10.4049\/jimmunol.1900456","volume":"204","author":"G Cui","year":"2020","unstructured":"Cui G, Shimba A, Ma G, Takahara K, Tani-Ichi S, Zhu Y, Asahi T, Abe A, Miyachi H, Kitano S, et al. IL-7R-Dependent phosphatidylinositol 3-kinase competes with the STAT5 signal to modulate T cell development and homeostasis. J Immunol. 2020;204(4):844\u201357.","journal-title":"J Immunol"},{"key":"509_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T cell exhaustion during chronic viral infection and cancer. Annu Rev Immunol. 2019;37:457\u201395.","journal-title":"Annu Rev Immunol"},{"key":"509_CR38","doi-asserted-by":"publisher","first-page":"105773","DOI":"10.1016\/j.intimp.2019.105773","volume":"75","author":"X Tian","year":"2019","unstructured":"Tian X, Su Z, Guo S, Wang C, Zhang X, Du J. Interleukin-7 promotes CD8(+) T cell activity in patients with enterovirus 71 associated encephalitis. Int Immunopharmacol. 2019;75:105773.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"509_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cellimm.2015.01.001","volume":"293","author":"S Cote","year":"2015","unstructured":"Cote S, Matte J, Sad S, Angel JB, Crawley AM. Complexed soluble IL-7 receptor alpha and IL-7 increase IL-7-mediated proliferation and viability of CD8(+) T-cells in vitro. Cell Immunol. 2015;293(2):122\u20135.","journal-title":"Cell Immunol"},{"issue":"26","key":"509_CR40","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1182\/blood-2008-05-155309","volume":"113","author":"S Colombetti","year":"2009","unstructured":"Colombetti S, Levy F, Chapatte L. IL-7 adjuvant treatment enhances long-term tumor-antigen-specific CD8+ T-cell responses after immunization with recombinant lentivector. Blood. 2009;113(26):6629\u201337.","journal-title":"Blood"},{"issue":"1\u20132","key":"509_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cellimm.2015.10.009","volume":"298","author":"A Saeidi","year":"2015","unstructured":"Saeidi A, Buggert M, Che KF, Kong YY, Velu V, Larsson M, Shankar EM. Regulation of CD8+ T-cell cytotoxicity in HIV-1 infection. Cell Immunol. 2015;298(1\u20132):126\u201333.","journal-title":"Cell Immunol"},{"key":"509_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1600-065X.1997.tb01010.x","volume":"159","author":"PC Doherty","year":"1997","unstructured":"Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev. 1997;159:105\u201317.","journal-title":"Immunol Rev"},{"issue":"5","key":"509_CR43","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1172\/JCI121668","volume":"129","author":"L Belarif","year":"2019","unstructured":"Belarif L, Danger R, Kermarrec L, Nerriere-Daguin V, Pengam S, Durand T, Mary C, Kerdreux E, Gauttier V, Kucik A, et al. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease. J Clin Invest. 2019;129(5):1910\u201325.","journal-title":"J Clin Invest"},{"issue":"13","key":"509_CR44","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1182\/blood-2012-06-434779","volume":"120","author":"R Cimbro","year":"2012","unstructured":"Cimbro R, Vassena L, Arthos J, Cicala C, Kehrl JH, Park C, Sereti I, Lederman MM, Fauci AS, Lusso P. IL-7 induces expression and activation of integrin alpha4beta7 promoting naive T-cell homing to the intestinal mucosa. Blood. 2012;120(13):2610\u20139.","journal-title":"Blood"},{"issue":"5","key":"509_CR45","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1517\/14728222.2014.893295","volume":"18","author":"K Pathak","year":"2014","unstructured":"Pathak K. The expanding role of IL-7 and thymic stromal lymphopoietin as therapeutic target for rheumatoid arthritis. Expert Opin Ther Targets. 2014;18(5):581\u201394.","journal-title":"Expert Opin Ther Targets"},{"key":"509_CR46","first-page":"2120453","volume":"2019","author":"X Huang","year":"2019","unstructured":"Huang X, Chen H, Xie Y, Cao Z, Lin X, Wang Y. FoxO1 overexpression ameliorates TNF-alpha-induced oxidative damage and promotes osteogenesis of human periodontal ligament stem cells via antioxidant Defense activation. Stem Cells Int. 2019;2019:2120453.","journal-title":"Stem Cells Int"},{"issue":"674","key":"509_CR47","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1126\/scisignal.abb1269","volume":"14","author":"A Koyas","year":"2021","unstructured":"Koyas A, Tucer S, Kayhan M, Savas AC, Akdemir I, Cekic C. Interleukin-7 protects CD8(+) T cells from adenosine-mediated immunosuppression. Sci Signal. 2021;14(674):1269.","journal-title":"Sci Signal"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-022-00509-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-022-00509-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-022-00509-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T18:04:43Z","timestamp":1700849083000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-022-00509-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1186\/s12865-022-00509-0","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"29 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved in compliance with the Declaration of Helsinki by the Ethics Committee at The First Hospital of Shanxi Medical University (Approval number: 2016-KY-08072\u00a0and 2021-K-K102). Written informed consent was obtained from all enrolled patients and controls.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}